News

As part of the deal, Atara will have the option to acquire a worldwide license to three clinical stage T-cell therapies. These therapies include T-cells activated against Epstein

The FDA fast track status helps in expediting the review and development of drugs which treat a serious or life-threatening condition and fill an unmet medical need. According

P. aeruginosa is a highly drug-resistant bacterial pathogen that causes serious disease in hospitalized patients. MEDI3902 is a new mAb engineered to combine three distinct mechanisms of action

More than 125 million people worldwide are affected by psoriasis, a chronic inflammatory disease of the skin resulting from an uncontrolled immune response. The FDA approval was primarily

Zestra is a topical treatment for female sexual desire disorder (FSDD), EjectDelay is indicated for premature ejaculation, Sensum+ is used to increase penile sensitivity, while Zestra Glide is

Blinatumomab, the first of the BiTE antibody constructs, is indicated to treat adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the

Onychomycosis is a fungal infection of the nail and nail bed that affects around 35 million people in the US. In July, Anacor entered into an exclusive agreement

The company’s French subsidiary TFChem has now moved into the next phase of the agreement with France-based contract research organization (CRO) Biogalenys to carry out the trials. Funding

MIN-202 is being developed by Minerva Neurosciences in collaboration with Janssen Pharmaceutica and Janssen Research & Development. The completion of the IND review will allow Janssen to start